APOL6抗体;APOL6 Antibody—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P11580(APOL6 Antibody) at dilution 1/60. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P11580(APOL6 Antibody) at dilution 1/60. (Original magnification: ×200)    

  
  

The APOL6 antibody is designed to target apolipoprotein L6 (APOL6), a member of the APOL protein family involved in innate immunity and cellular stress responses. APOL proteins (APOL1-6) are characterized by lipid-binding domains and play roles in pathogen defense, apoptosis, and autophagy. APOL6. though less studied than APOL1 (linked to kidney disease) or APOL3 (associated with lipid metabolism), is suggested to participate in intracellular membrane trafficking, inflammation modulation, and cell death pathways. It is expressed in various tissues, including the liver, immune cells, and epithelial cells.

Research on APOL6 remains limited, but studies indicate its potential involvement in cancer progression and viral defense. For instance, APOL6 may interact with autophagy-related proteins or influence endoplasmic reticulum stress, affecting tumor cell survival. Antibodies against APOL6 are primarily used in research to elucidate its expression patterns, subcellular localization, and molecular interactions via techniques like Western blotting, immunohistochemistry, or immunofluorescence.

Developing specific APOL6 antibodies is challenging due to homology within the APOL family. However, such tools are critical for exploring APOL6’s biological roles and its relevance to diseases like cancer, metabolic disorders, or infections. Future studies may clarify its therapeutic potential as a biomarker or drug target.